Inventor · disambiguated record
Daryl Sauer
Also filed as: SAUER DARYL · SAUER DARYL R · SAUER DARYL RICHARD
22 granted patents·16 pending applications·180 citations·filing 1994–2021
94Inventor score
Top patents by PatentIndex Score
38 records- 0193US8350055B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBOTT GMBH & CO KG·Filed 2010·Granted Jan 8, 2013·23 cites·8 claims
- 0290US7902379B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBOTT GMBH & CO KG·Filed 2004·Granted Mar 8, 2011·27 cites·4 claims
- 0389US8183250B2Potent PARP inhibitorsPENNING THOMAS D·Filed 2009·Granted May 22, 2012·15 cites·9 claims
- 0489US7910742B2Survivin inhibitorsABBOTT LAB·Filed 2006·Granted Mar 22, 2011·9 cites·1 claims
- 0577US9242933B2Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)GENESTE HERVE·Filed 2008·Granted Jan 26, 2016·3 cites·18 claims
- 0677US8445686B24-(4-pyridinyl)-benzamides and their use as rock activity modulatorsMACK HELMUT·Filed 2008·Granted May 21, 2013·3 cites·21 claims
- 0776US7320979B2N-[(piperazinyl)hetaryl]arylsulfonamide compoundsABBOTT GMBH & CO KG·Filed 2004·Granted Jan 22, 2008·7 cites·22 claims
- 0875US8895749B24-(4-pyridinyl)-benzamides and their use as rock activity modulatorsABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 25, 2014·2 cites·11 claims
- 0974US6020521AMacrolide LHRH antagonistsABBOTT LAB·Filed 1998·Granted Feb 1, 2000·45 cites·12 claims
- 1073US8580842B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themLUBISCH WILFRIED·Filed 2010·Granted Nov 12, 2013·2 cites·5 claims
- 1170US9487505B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 8, 2016·1 cites·8 claims
- 1270US6495562B1Naphthamidine urokinase inhibitorsABBOTT LAB·Filed 2001·Granted Dec 17, 2002·5 cites·18 claims
- 1367US2007043089A1Method of inhibiting angiogenesisHAVIV FORTUNA·Filed 2006·Application pending·0 cites
- 1467US2007032527A1Method of inhibiting angiogenesisHAVIV FORTUNA·Filed 2006·Application pending·0 cites
- 1562US2004116479A1Method of inhibiting angiogenesisFiled 2003·Application pending·0 cites
- 1661US5955440AMacrolide LHRH antagonistsABBOTT LAB·Filed 1998·Granted Sep 21, 1999·19 cites·15 claims
- 1759US2007021607A1Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBOTT GMBH & CO KG·Filed 2006·Application pending·0 cites
- 1858US2015105386A14-(4-pyridinyl)-benzamides and their use as rock activity modulatorsABBVIE DEUTSCHLAND·Filed 2014·Application pending·0 cites
- 1956US2005070718A1Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBOTT GMBH & CO KG·Filed 2003·Application pending·0 cites
- 2055US2007054918A1N-[(piperazinyl)hetary]arylsulfonamide compounds with affinity for the dopamine d3 receptorBRAJE WILFRIED·Filed 2004·Application pending·0 cites
- 2154US2008015182A1Potent PARP InhibitorsPENNING THOMAS D·Filed 2007·Application pending·0 cites
- 2253US2004204422A1N-[(Piperazinyl)hetaryl]arylsulfonamide compoundsABBOTT GMBH & CO KG·Filed 2003·Application pending·0 cites
- 2352US8476275B2N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptorBRAJE WILFRIED·Filed 2011·Granted Jul 2, 2013·0 cites·3 claims
- 2450US11807600B2Synthesis of novel ketone body analogs for use as a nutritional supplementROZZONI SAMUEL J·Filed 2021·Granted Nov 7, 2023·0 cites·20 claims
- 2550US2019134133A1Composition for reducing anxiety in a companion animalWISYS TECH FOUNDATION INC·Filed 2018·Application pending·0 cites
- 2649US8114875B2Substituted N-heterocyclic compounds and their use as dopamine D3 receptor ligandsGENESTE HERVE·Filed 2005·Granted Feb 14, 2012·0 cites·9 claims
- 2749US2006030557A1Substituted pyridines having antiangiogenic activityHAVIV FORTUNA·Filed 2005·Application pending·0 cites
- 2848US8207160B2Tetrahydrobenzazepines and their use in he modulation of the dopamine D3 receptorBRAJE WILFRIED·Filed 2004·Granted Jun 26, 2012·0 cites·15 claims
- 2948US2004014744A1Substituted pyridines having antiangiogenic activityFiled 2003·Application pending·0 cites
- 3047US2003195195A1Substituted pyridines having antiangiogenic activityFiled 2002·Application pending·0 cites
- 3146US7592466B2Ureas having antiangiogenic activityABBOTT LAB·Filed 2004·Granted Sep 22, 2009·0 cites·6 claims
- 3246US2005137186A1Tetrahydrobenzazepines and their useABBOTT GMBH & CO KG·Filed 2003·Application pending·0 cites
- 3345US5508383ACyclic peptide LHRH antagonistsTAP HOLDINGS INC·Filed 1994·Granted Apr 16, 1996·7 cites·1 claims
- 3443US6387885B13′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonistsABBOTT LAB·Filed 1998·Granted May 14, 2002·4 cites·13 claims
- 3541US2004067985A1Method of inhibiting angiogenesisFiled 2002·Application pending·0 cites
- 3639US5972898A3',3-N-bis-substituted macrolide LHRH antagonistsABBOTT LAB·Filed 1998·Granted Oct 26, 1999·4 cites·16 claims
- 3739US2017050959A1Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 3831US5491217ALHRH antagonists having modified aminoacyl residues at positions 5 and 6TAP HOLDING INC·Filed 1994·Granted Feb 13, 1996·4 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →